Displaying 37 - 48 of 101
Metabolism, Alcohol & Toxicity
6

Boehringer Ingelheim: MASH in focus: novel insights on diagnosis, management and coordinated patient care - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
6

Boehringer Ingelheim: MASH in focus: novel insights on diagnosis, management and coordinated patient care - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
6

Boehringer Ingelheim: MASH in focus: novel insights on diagnosis, management and coordinated patient care - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
6

Boehringer Ingelheim: MASH in focus: novel insights on diagnosis, management and coordinated patient care - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
8

Sanofi: Reducing the burden of liver disease - new evidence revealed - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
3

Mirum: Meet the Experts in Cholestatic Liver Disease - EASL Congress 2024

View
Displaying 37 - 48 of 101